STOCKHOLM, May 4, 2016 – Elekta (EKTA-B.ST) invites equity analysts, investors
and media representatives to Elekta’s Capital Markets Day on June 9 at Norra
Latin, Drottninggatan 71b in Stockholm, entrance from Barnhusgatan.
Presentations will start at 13:30 CET and will end at approximately 16:30 CET.
Speakers at the event will include Tomas Puusepp, Elekta’s President and CEO,
and other members of Elekta’s management team. Richard Hausmann, who will
succeed Tomas Puusepp as President and CEO, effective from June 10, 2016, will
also be present at the event.
To attend, please register through the following link:
https://www.elekta.com/investors/cmd-registration/index.php no later than May
25, 2016.
It will also be possible to follow the Capital Markets Day over the phone and as
a live webcast. However, please note that we only will be able to take questions
from the participants on location at the Capital Markets Day.
Live webcast: http://elekta-live.creo.tv/cmd-2016/
To take part over the phone, please dial in about 5-10 minutes in advance.
· Sweden: +46 8 566 426 90
· UK: +44 20 3008 9801
· US: +1 855 753 2235
We look forward to your participation on June 9, 2016.
Kind regards,
Johan Andersson
Director Investor Relations
Tobias Bülow
Director Financial Communication
Frida Johansson
Investor Relations
# # #
For further information, please contact:
Frida Johansson, Investor Relations, Elekta AB (publ)
Tel: +46 70 866 7674, e-mail: Frida.Johansson@elekta.com
Time zone: Central European Time
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on NASDAQ Stockholm. Website: www.elekta.com.
